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A B S T R A C T
Babesia is known to be prevalent in the Eastern United States and other temperate countries but the
prevalence of babesia is not well known in the tropical malaria-endemic countries because of the higher
prevalence of malaria.
A 72-year-old Hispanic male from Ecuador presenting with increasing left lower quadrant abdominal
pain and distention for one year. He experienced nausea, vomiting, diarrhea, fever, chill, and myalgias.
He reported 9 kg weight loss over the last two months. Patient moved to Chicago recently from Ecuador
where he worked at a banana plantation and had frequent exposure to many insects and animals.
Vital signs were normal but patient appeared chronically ill. Mild tenderness to palpation over the left
side of the abdomen with marked splenomegaly, measuring 16 cm below the costal margin.
Laboratory results with no leukocytosis hemoglobin 7.8  109/L; and platelet count, 55  109/L.
Sodium was 128 mmol/L. Labs showed elevated LDH, ESR and ferritin values. The haptoglobin was low
with a positive Combs test. CT abdomen showed moderate splenomegaly with large patchy, wedge-
shaped hypodense area in posterior mid and upper spleen suggesting splenic infarction. Rapid malaria
screening was negative, but a peripheral smear identiﬁed plasmodium species in more than 0.5% of red
blood cells. Treatment with atovaquone and proguanil started.
Two weeks later, molecular testing revealed Babesia DNA.
This report details a case of babesiosis in a patient coming from a malaria-endemic region. The initial
workup and blood work highly suggested a plasmodium infection. However the polymerase chain
reaction conﬁrmed the diagnosis of a Babesia microti.
Learning objectives: We report the ﬁrst case of human Babesiosis in previously healthy individual
from Ecuador.
Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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This report details a case of babesiosis in a patient coming from
Ecuador, where no babesiosis has been reported from this malaria-
endemic region. The initial presentation and blood work highly
suggested Plasmodium infection. However, the polymerase chain
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A 72-year-old Hispanic male from Ecuador with a history of
hypertension was admitted to the hospital for increasing right
lower quadrant abdominal pain and distention which started a
year before but worsened in the past two months. He had been
experiencing nausea, vomiting, diarrhea, dry cough, fever, chill,
headaches and myalgias. He reported a 9 kg weight loss over the
last two months, which he attributed to decreased appetite. He
denied rash, jaundice, or hematochezia. Patient moved to Chicago
two months previously from Ecuador where he worked at a banana
plantation and had frequent exposure to many insects and animals.
On physical examination, vital signs were normal but patient
appeared chronically ill. Mild tenderness to palpation of the
abdomen was noted on the left side with marked splenomegaly,
measuring 16 cm below the costal margin. There was no evidenceC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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nodes.
Laboratory results included the following (reference ranges
provided parenthetically): hemoglobin, 12.1 g/dL (13.5–17.5 g/
dL); mean corpuscular volume, 84.0 fL (81.2–95.1 fL); white blood
cell count, 7.8  109/L (3.5–10.5  109/L); and platelet count,
55  109/L (150–450  109/L). An electrolyte panel yielded normal
ﬁndings except for a sodium level of 128 mmol/L (135–145 mmol/L).
Labs were also notable for elevated LDH, ESR and ferritin values. Total
bilirubin was 1.3 with a direct bilirubin of 0.4. The haptoglobin was
low with a positive Combs test. Moreover, blood culture had been
negative for 3 days.
CT chest with contrast to look for possible accessible lymph
nodes showed no evidence of acute intrathoracic process and no
evidence of mediastinal, hilar or axillary adenopathy. CT of the
abdomen and pelvis (Fig. 1A) showed moderate splenomegaly with
large patchy, wedge-shaped hypodense area in posterior mid and
upper spleen extending toward hilum, suggesting splenic infarc-
tion. Abdominal ultrasound (Fig. 1B) showed splenomegaly with
an 11 mm hyperechoic lesion on the spleen, which probably
represented a small hemangioma. Rapid malaria screening came
back negative, but peripheral blood smear (Fig. 1C and D) showed
0.5% of red blood cells containing intraerythrocytic parasites
suggestive of plasmodium species. A 3-day treatment course of
atovaquone and proguanil was begun for active malaria.Fig. 1. (A) CT abdomen and pelvis with contrast. Large heterogeneous spleen and perisp
lesion in the spleen probably represents a hemangioma. (C) Peripheral blood smear show
blood smear showing red blood cell containing round to oval shaped ring.A diagnosis of hyperreactive malarial splenomegaly [1,2] was
made, which is a rare immunologic complication of chronic
malarial infection. IgM, IgG Malaria, cryoglobulins, and cold
agglutinins were sent. Although the patient failed to meet all the
Fakunle criteria to diagnose HMS, the clinical suspicion was high,
especially when the malaria IgG came back elevated to 6.44. Blood
was also sent to the CDC for diagnostic conﬁrmation. Primaquine
was started for treatment of a persistent hypnozoite stage after
the G6PD level was found to be normal. Results of HIV, viral
hepatitis serology and ANA panel were negative. During the
following days, the patient reported feeling well, although with
little appetite, his abdominal pain and distention had remarkably
improved. This required extensive discussion about the impor-
tance of completing the antimalarial medication as well as
following up with a primary physician in Ecuador in the case of
long term malaria prophylaxis. The patient had to be educated
about the importance of the avoidance of physical activity,
driving, and horse riding while his spleen remained enlarged, as
well as the risks of splenic hemorrhage. The patient was
discharged and given a cycle of primaquine to ﬁnish in a total
course of 14 days.
Two weeks later, we received a call from the CDC stating that
molecular testing revealed Babesia microti DNA, although the
peripheral blood smear did not demonstrate the classic parasite
forms.lenic thickening. (B) Abdominal ultrasound of the spleen. Focal 11 mm hyperechoic
ing red blood cell containing highly complex rings and fused forms. (D) Peripheral
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One of the challenges of clinicians is the diagnosis of two
different diseases with similar signs and symptoms. Two diseases
that share the same qualities are malaria and babesiosis in where
the pathophysiology, symptoms, and physical exam ﬁndings are
remarkably similar. Both Babesia and Plasmodium are intraery-
throcytic protozoa. In the case of babesia, the sporozoite infects the
red blood cell, afterwards develops into a trophozoite. It also
further develops into merozoite within the red blood cell, which
can be seen as the ‘‘Maltese cross’’ pattern on peripheral blood
smear. In the case of malaria, the Plasmodium sporozoite is
injected into the blood from the bite of the anopheles mosquito.
The sporozoite subsequently travels to the liver where it
reproduces asexually into multiple merozoites. The merozoites
then infect the red blood cells where it will multiply further and be
released to infect even more red blood cells. These protozoa have
similar pathophysiology, and the diseases caused by them also
have similar symptoms such as fever, chills, sweats, fatigue,
headache, nausea, vomiting, body aches, and malaise [3–5]. These
symptoms are likely caused by the cytokines released when the
infected red blood cell becomes destroyed [6]. Also physical exam
ﬁndings can also be quite similar such as anemia, jaundice and
splenomegaly. Differentiating these diseases out from one another
required a good clinical, travel, occupational, and leisure history
with lab testing.
The most common form of Babesia is the intraerythrocytic
round or oval ring, with a pale blue cytoplasm and one or two red
chromatic dots [7]. However, this ring forms may be mistaken for
Plasmodium falciparum trophozoites. There are several distinguish-
ing features of babesia from plasmodium. Babesia merozoites are
occasionally arranged tetrads (‘‘Maltese Cross’’) which is patho-
gnomonic of B. microti and B. duncani [8]. Gametes and schizonts
are not observed in babesiosis [9]. Extracellular merozoites, either
single or in clumps, may be seen with high levels of parasitemia in
babesia. Babesia lacks brownish pigment deposits (hemozoin) in
infected RBC, which is typically seen in older rings of P. falciparum
infection [9]. A polymerase chain reaction can be required to
differentiate the protozoan infections. This advanced testing for
babesia is not readily available to many practitioners in malaria
endemic countries where babesia is also present.
Babesiosis is known to be prevalent in the Eastern United States
and other temperate countries but the prevalence of babesiosis is
not well known in the tropical malaria-endemic countries because
of the higher prevalence of malaria. However, it is known that
cattle babesiosis is a large problem with signiﬁcant economic costs
[10]. The most prevalent species of babesia that infect cattle and
livestock in South America are Babesia bigemina and Babesia boviswhich the latter is more pathogenic [10]. The tick vector of cattle
babesiosis is primarily Boophilus microplus, which is distributed
globally throughout the tropics [10]. This species is not thought to
bite humans unlike the Ixodes tick [11]. However, there have been
a few rare cases where Babesia spp. that normally infect cattle and
other animals to cause disease in humans especially if they are
asplenic or immunocompromised [11].
This report details a case of babesiosis in a patient coming from
a malaria-endemic region. The initial workup and blood work
highly suggested a plasmodium infection. However the polymer-
ase chain reaction conﬁrmed the diagnosis of a Babesia microti
infection. Asymptomatic infections with Babesia that infect
domestic animals have been reported from Mexico (B. bigemina,
B. canis) and Columbia (B. bigemina, B. bovis) [9,12]. To the best of
our knowledge, this is the ﬁrst case of human babesiosis from
Ecuador.
Human babesiosis is a rare but devastating and potentially
lethal infectious disease. Timely diagnosis and treatment are
important but often delayed. It necessitates increased physician
awareness to distinguish from similar infection, such as malaria.
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